Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study

Fig. 1

Study schedule. Treatment-naïve neovascular age-related macular degeneration (nAMD) patients received intravitreal injections of ranibizumab (IVR) (0.5 mg) as needed with monthly monitoring after three initial monthly doses. BCVA = best-corrected visual acuity. OCT = optical coherence tomography. FA = fluorescein angiography. IA = indocyanine green angiography. VFQ-25 = The 25-item National Eye Institute Visual Function Questionnaire

Back to article page
\